Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Bluebird Bio (NQ: BLUE ) 0.9231 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jul 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Bluebird Bio < Previous 1 2 ... 5 6 7 8 9 10 11 12 Next > What's Next For Cell Therapy In Oncology? Enlivex (NASDAQ: ENLV) Says It Has The Answers October 25, 2022 Since Robert Hooke discovered cells in 1665 and Theodor Schwann proposed the classical cell theory in 1839, the cell therapy industry has grown by leaps and bounds. Via Benzinga Why Legend Biotech's Shares Jumped 14.2% On Tuesday October 18, 2022 The company presented news regarding early revenue figures for a multiple myeloma therapy it collaborated on. Via The Motley Fool Biotech Stocks Well-Positioned For The Fourth Quarter October 12, 2022 The path of interest rates is clearer for 2022 and the FED is closer to a pause early next year as it calibrates its response from a hammer approach so far. Via Talk Markets Bluebird Bio Offers World's Most Expensive Drugs, But Uncertainty Looms Over Its Financial Future October 03, 2022 Bluebird Bio Inc (NASDAQ: BLUE) is about to become the seller of the two most expensive drugs in the U.S. and probably the world. The price tag of $3 million is already facing backlash. Via Benzinga AstraZeneca-Merck's Prostate Cancer Combo Drug, 3rd Try For scPharma, 3 FDA Panel Decisions And More: October's Key PDUFA Catalysts Biotech Investors Must Know October 02, 2022 Most FDA decisions scheduled for September yielded positive results, but there were stray disappointments as well. Seven new molecular entities, or NMEs, were approved during the month, taking the... Via Benzinga Short Volatility Alert: bluebird bio, Inc. September 22, 2022 On Wednesday, shares of bluebird bio, Inc. (NASDAQ: BLUE) experienced volatile short activity. After the activity, the stock price went down -10.06% to $6.17. The overall sentiment for BLUE has been... Via Benzinga What 5 Analyst Ratings Have To Say About bluebird bio September 20, 2022 Analysts have provided the following ratings for bluebird bio (NASDAQ:BLUE) within the last quarter: Via Benzinga Why F45 Training Shares Climbed 41%; Here Are 84 Biggest Movers From Friday October 03, 2022 Gainers FingerMotion, Inc. (NASDAQ: FNGR) gained 82.2% to close at $3.37. Via Benzinga Why Carnival Shares Are Trading Lower By 19%, Here Are 49 Stocks Moving In Friday's Mid-Day Session September 30, 2022 Gainers Via Benzinga Micron, Charles River Laboratories And Some Other Big Stocks Moving Higher On Friday September 30, 2022 U.S. stocks traded slightly higher, with the Nasdaq Composite gaining more than 80 points on Friday. Here are some big stocks recording gains in today’s session. Via Benzinga US Stock Futures Mixed After Recording Losses Last Week; Fed Speakers In Focus September 26, 2022 Pre-open movers Via Benzinga Amazon, bluebird bio And 3 Stocks To Watch Heading Into Monday September 26, 2022 With US stock futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows: Via Benzinga Stitch Fix, Tellurian And Some Other Big Stocks Moving Lower In Today's Pre-Market Session September 21, 2022 U.S. stock futures traded slightly higher this morning after recording losses in the previous session. Here are some big stocks moving lower in today’s pre-market trading session. Via Benzinga Why ECMOHO Is Trading Lower By 29%; Here Are 28 Stocks Moving Premarket September 21, 2022 Gainers Ampio Pharmaceuticals, Inc. (NYSE: AMPE) rose 17.8% to $0.0942 in pre-market trading after declining around 5% on Tuesday. Via Benzinga Why SOBR Safe Shares Surged Around 233%; Here Are 68 Biggest Movers From Yesterday September 21, 2022 Gainers Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session September 20, 2022 Via Benzinga Why Virios Therapeutics Is Trading Lower By 75%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session September 20, 2022 Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 51% to $0.4957. Crown ElectroKinetics, last month, posted a Q4 net loss of $4.5 million. Via Benzinga Cognex, Oxford Industries And Some Other Big Stocks Moving Higher On Tuesday September 20, 2022 U.S. stocks traded lower, with the Dow Jones dropping more than 400 points on Tuesday. Here are some big stocks recording gains in today’s session. Via Benzinga NIKE Price Target Cut By This Analyst; Also Benchmark Sees $325 For Danaher September 20, 2022 Barclays cut the price target on NIKE, Inc. (NYSE: NKE) from $125 to $110. Barclays analyst Adrienne Yih also downgraded the stock from Overweight to Equal-Weight. NIKE shares fell 4.3% to trade at... Via Benzinga Nikola, Super Micro Computer And Other Big Losers From Monday September 20, 2022 U.S. stocks closed higher with the Dow Jones gaining around 197 points on Monday. Here is the list of some big stocks recording losses in the previous session. Via Benzinga Why KnowBe4 Shares Jumped Over 28%; Here Are 79 Biggest Movers From Yesterday September 20, 2022 Gainers Ventoux CCM Acquisition Corp. (NASDAQ: VTAQ) shares jumped 54.6% to settle at $7.05 on Monday. Via Benzinga Why Virios Therapeutics Is Trading Lower By Over 71%, Here Are 55 Stocks Moving In Monday's Mid-Day Session September 19, 2022 Gainers MicroCloud Hologram Inc. (NASDAQ: HOLO) shares jumped 134.6% to $19.74. Via Benzinga What's Going On With Bluebird Bio Stock Today? September 19, 2022 Bluebird Bio Inc (NASDAQ: BLUE) shares are trading lower Monday. The stock initially surged in premarket trading following the U.S. Food and Drug Administration's accelerated approval of SKYSONA, but... Via Benzinga AutoZone (AZO) Stock Pops as Sales Beat Expectations September 19, 2022 AutoZone (AZO) stock is rising on Monday following the release of the automotive part company's earnings report for fiscal Q4 2022. Via InvestorPlace Bluebird Bio (BLUE) Stock Is in Focus Following FDA Approval September 19, 2022 The Boston-based biotech company has secured FDA approval for one of its gene therapies. Let's take a closer look at BLUE stock. Via InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday September 19, 2022 We're starting off the week with a breakdown of the biggest pre-market stock movers for Monday morning and the news behind them! Via InvestorPlace Why bluebird bio Is Trading Higher By Around 19%; Here Are 31 Stocks Moving Premarket September 19, 2022 Gainers FOXO Technologies Inc. (NYSE: FOXO) rose 161% to $10.50 in pre-market trading after dipping 52% on Friday. Via Benzinga US Stock Futures Down Ahead Of Fed's Rate Decision This Week, Crude Oil Drops Over 1% September 19, 2022 Pre-open movers U.S. stock futures traded lower in early pre-market trade on Monday after recording losses on Friday. All the three major indices recorded losses last week, with the Dow Jones dropping... Via Benzinga AutoZone, bluebird bio And 3 Stocks To Watch Heading Into Monday September 19, 2022 With US stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows: Via Benzinga FDA Okays bluebird bio's $3M Gene Therapy For Rare Neurological Disorder In Boys: What Investors Should Know September 17, 2022 Biotechnology company, bluebird bio, Inc. (NASDAQ: BLUE) announced late Friday that the Food and Drug Administration approved its gene therapy for a rare neurodegenerative disease. Via Benzinga < Previous 1 2 ... 5 6 7 8 9 10 11 12 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.